Literature DB >> 31424514

Genetic epidemiology of colorectal cancer and associated cancers.

Hongyao Yu1,2, Kari Hemminki1.   

Abstract

We review here data on familial risk in colorectal cancer (CRC) generated from the Swedish Family-Cancer Database, the largest resource of its kind in the world. Although the concordant familial risk for CRC (i.e. CRC risk in families of CRC patients) has been reasonably well established, the studies on discordant familial risks (i.e. CRC risk in families with any other cancers) are rare. Because different cancers could be caused by shared genetic susceptibility or shared environment, data of associations of discordant cancers may provide useful information for identifying common risk factors. In analyses between any of 33 discordant cancers relative risks (RRs) for discordant cancers were estimated in families with increasing numbers of probands with CRC; in the reverse analyses, RRs for CRC were estimated in families with increasing numbers of probands with discordant cancers. In separate analyses, hereditary non-polyposis colorectal cancer (HNPCC) families were excluded from the study, based on HNPCC related double primary cancers, to assess the residual familial RRs. We further reviewed familial risks of colon and rectal cancers separately in search for distinct discordant associations. The reviewed data suggested that colon cancer was associated with a higher familial risk for CRC compared to rectal cancer. The previous data had reported associations of CRC with melanoma, thyroid and eye cancers. Nervous system cancer was only associated with colon cancer, and lung cancer only associated with rectal cancer. The reviewed data on discordant association may provide guidance to gene identification and may help genetic counseling.
© The Author(s) 2019. Published by Oxford University Press on behalf of the UK Environmental Mutagen Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Year:  2020        PMID: 31424514     DOI: 10.1093/mutage/gez022

Source DB:  PubMed          Journal:  Mutagenesis        ISSN: 0267-8357            Impact factor:   3.000


  5 in total

Review 1.  The functions of N6-methyladenosine (m6A) RNA modifications in colorectal cancer.

Authors:  Haiyan Qiao; Linfeng Liu; Jun Chen; Bingbing Shang; Liang Wang
Journal:  Med Oncol       Date:  2022-09-29       Impact factor: 3.738

Review 2.  Granzymes-Their Role in Colorectal Cancer.

Authors:  Sara Pączek; Marta Łukaszewicz-Zając; Barbara Mroczko
Journal:  Int J Mol Sci       Date:  2022-05-09       Impact factor: 6.208

3.  Survival in bladder and upper urinary tract cancers in Finland and Sweden through 50 years.

Authors:  Kari Hemminki; Asta Försti; Akseli Hemminki; Börje Ljungberg; Otto Hemminki
Journal:  PLoS One       Date:  2022-01-04       Impact factor: 3.240

Review 4.  Molecular Pathogenesis of Colorectal Cancer with an Emphasis on Recent Advances in Biomarkers, as Well as Nanotechnology-Based Diagnostic and Therapeutic Approaches.

Authors:  Fakhria A Al-Joufi; Aseem Setia; Mounir M Salem-Bekhit; Ram Kumar Sahu; Fulwah Y Alqahtani; Retno Widyowati; Fadilah Sfouq Aleanizy
Journal:  Nanomaterials (Basel)       Date:  2022-01-04       Impact factor: 5.076

5.  Identification of COX4I2 as a hypoxia-associated gene acting through FGF1 to promote EMT and angiogenesis in CRC.

Authors:  Jie-Pin Li; Yuan-Jie Liu; Shu-Hong Zeng; Hai-Jian Gao; Yu-Gen Chen; Xi Zou
Journal:  Cell Mol Biol Lett       Date:  2022-09-05       Impact factor: 8.702

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.